Hypertension Trial, Recruiting NCT05445544 Sponsor: Zhujiang Hospital Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05445544
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are currently pregnant
  • People who are carrying one baby (not twins or more)
  • People who are willing to attend regular pregnancy check-ups at one of the research centres
  • People who are willing to sign a written consent form to take part

Who may not be able to join:

  • People who had high blood pressure, diabetes, liver disease, kidney disease, blood disorders, or other serious health conditions before becoming pregnant, including those who need long-term medication for these conditions
  • People who have had preeclampsia (a serious blood pressure condition during a previous pregnancy) in the past
  • People who have a tumour or a serious infection that requires long-term treatment with medication
  • People who became pregnant through IVF (in vitro fertilisation)
  • People who are carrying more than one baby (twins, triplets, etc.)
  • People whose pregnancy has already been identified as needing to be ended for medical reasons early in the pregnancy
  • People whose doctor considers them unsuitable for the study for any other medical or personal reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: hongwei zhou, Zhujiang Hospital

Phone: 15622136950

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhujiang Hospital
Registry
ClinicalTrials.gov
Start date
19 October 2022
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

microbiome; proteomics; metabonomics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov